You are currently viewing Pharmatest receives approval of the French Tax Credit Incentive (Crédit d’Impôt Recherche CIR)

Pharmatest receives approval of the French Tax Credit Incentive (Crédit d’Impôt Recherche CIR)

  • Post published:

Pharmatest has received the renewal of its French Tax Credit approval for the years 2024-2028.

What is French Tax Credit?

The French Tax Credit Incentive (Crédit d’Impôt Recherche CIR) is a tax relief for organizations based in France that outsource their Research & Development activities to third parties, such as Pharmatest. The incentive is up to 30% tax reduction of all Research & Development expenses.

The basis of eligibility for receiving the approval is conducting company’s own Research & Development studies and investment in Research & Development within the European Economic Area.

For more information on CIR benefits and filing, please visit the Ministry of Higher Education, Research and Innovation website.